<?xml version='1.0' encoding='utf-8'?>
<regulation prefix="Regulation" num=".01" citation="COMAR 10.13.03.01" title_num="10" subtitle_num="13" chapter_num="03" heading="Scope.">
  <text>This chapter applies to all licensed health care practitioners who may prescribe an opioid overdose reversal drug to an individual who:</text>
  <paragraph num="A.">
    <text>May be at an elevated risk of experiencing an opioid overdose including, but not limited to, an individual who:</text>
    <paragraph num="(1)">
      <text>Is receiving an opioid for chronic pain;</text>
    </paragraph>
    <paragraph num="(2)">
      <text>Is receiving an opioid and a prescription for a benzodiazepine; or</text>
    </paragraph>
    <paragraph num="(3)">
      <text>Has an opioid use disorder; or</text>
    </paragraph>
  </paragraph>
  <paragraph num="B.">
    <text>Resides or spends time with an individual who:</text>
    <paragraph num="(1)">
      <text>Is prescribed opioids;</text>
    </paragraph>
    <paragraph num="(2)">
      <text>Misuses opioids; or</text>
    </paragraph>
    <paragraph num="(3)">
      <text>Has an opioid use disorder.</text>
    </paragraph>
  </paragraph>
</regulation>